Clinical trials
Platelet Transfusion clinical trials
Below are recruiting platelet transfusion clinical trials, each written for real people, not researchers. We’re tracking 14 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06676904Recruiting
Platelet transfusion study for very preterm babies
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
Birmingham, AlabamaAges 1 hour–2 days - NCT06792019RecruitingPhase 1/Phase 2
Study of CM313 injection for platelet transfusion resistance
This trial tests a new drug called CM313 to see if it can help people whose platelet transfusions stop working. It is for adults who need platelet transfusions and have developed antibodies against them.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06254560RecruitingPhase 2
Rituximab for severe aplastic anemia with platelet transfusion problems
This study tests if the drug rituximab can help people with severe aplastic anemia whose bodies have stopped responding to platelet transfusions. It aims to see if rituximab can improve the body's ability to accept platelets again.
Tianjin, Tianjin MunicipalityAges 18–70 - NCT05038722Enrolling by invitation
Testing how platelet transfusions work in people with low platelets
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
LinköpingAges 18 years+ - NCT07354672Recruiting
Experience with germ-reduced platelet transfusions in Germany
This study is looking at how well a special method works that treats platelets to kill germs (pathogens) before they are given to patients. It may be a good fit if you need regular platelet transfusions because your body doesn't make enough platelets.
Ulm, Baden-WurttembergAges 18 years+ - NCT06613425RecruitingPhase 4
Study of combined platelet transfusion
This trial tests a combined approach to platelet transfusion to see if it works better. It may help patients who need platelet transfusions as part of their hospital treatment.
Chengdu, SichuanAges 18–65 - NCT06433622Enrolling by invitation
Platelet transfusion for severe brain injury on blood thinners
This trial tests whether giving a platelet transfusion to patients with severe traumatic brain injury who are on antiplatelet medication can improve how well their blood clots. You may qualify if you have a serious brain bleed and are taking a medication like aspirin or clopidogrel.
Lancaster, PennsylvaniaAges 18 years+ - NCT03848923Recruiting
Study bleeding and inflammation in low-platelet newborns
This study looks at how very low platelet levels (and platelet transfusions, if needed) affect bleeding and inflammation in newborns. It may help doctors better understand which newborns are at higher risk and how to manage low platelets.
Boston, MassachusettsAges birth–6 months - NCT04448184RecruitingPhase 3
Platelet transfusion strategy during stem cell transplant
This trial compares how platelets are given during a stem cell transplant to help prevent bleeding. It also watches for clotting risks, since platelets can affect both bleeding and clot formation.
Calgary, AlbertaAges 18 years+ - NCT06805097Recruiting
Platelet transfusion for low platelet counts in blood cancer patients
This trial tests how well platelet transfusions work for patients with blood cancers or bone marrow failure who have very low platelets and need a transfusion. It aims to see if the transfusions help control bleeding and improve outcomes.
BesançonAges 18 years+ - NCT07072247RecruitingPhase 1
RN1201 injection for hard-to-treat antibody-mediated blood disorders
This trial tests a new injection called RN1201 for people with antibody-mediated diseases, specifically two types of blood disorders: platelet transfusion refractoriness (PTR) and immune thrombocytopenia (ITP) that haven't responded to standard treatments. The goal is to see if RN1201 can help control these conditions.
Suzhou, JiangsuAges 16–65 - NCT07230067Recruiting
Sepsis with low platelets: platelet transfusion study
This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.
Guangzhou, GuangdongAges 18 years+ - NCT05711485Recruiting
Test whole-blood transfusion plan for severe malaria in young children
This trial studies a platelet-focused strategy for giving whole blood to children under 5 with severe malaria. It aims to see whether this approach can improve care while keeping children safe.
Baltimore, MarylandAges 6 months–4.9 years - NCT06809010Recruiting
Blood storage study for group O donors
This study looks at how storing whole blood from group O donors affects blood cells and inflammation. It may help improve blood transfusions for patients.
Saint-EtienneAges 18–65
Hear when a new Platelet Transfusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for platelet transfusion?
- Yes. Clin2 currently lists 14 recruiting platelet transfusion studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a platelet transfusion trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a platelet transfusion trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.